Back
Results - Announcements
Sales rise 9.39% to Rs 237.48 crore
Orchid Pharma consolidated net profit declines 32.37% in the March 2025 quarter
27-May-2025, 07:37
Net profit of Orchid Pharma declined 32.37% to Rs 22.29 crore in the quarter ended March 2025 as against Rs 32.96 crore during the previous quarter ended March 2024. Sales rose 9.39% to Rs 237.48 crore in the quarter ended March 2025 as against Rs 217.10 crore during the previous quarter ended March 2024.
Net profit of Orchid Pharma declined 32.37% to Rs 22.29 crore in the quarter ended March 2025 as against Rs 32.96 crore during the previous quarter ended March 2024. Sales rose 9.39% to Rs 237.48 crore in the quarter ended March 2025 as against Rs 217.10 crore during the previous quarter ended March 2024.
For the full year,net profit rose 8.13% to Rs 99.66 crore in the year ended March 2025 as against Rs 92.17 crore during the previous year ended March 2024. Sales rose 12.52% to Rs 921.93 crore in the year ended March 2025 as against Rs 819.37 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. | |
| Sales | 237.48 | 217.10 | 9 | 921.93 | 819.37 | 13 |
| OPM % | 11.78 | 13.32 | - | 12.71 | 13.51 | - |
| PBDT | 27.97 | 38.80 | -28 | 130.11 | 125.18 | 4 |
| PBT | 19.09 | 30.38 | -37 | 95.56 | 91.95 | 4 |
| NP | 22.29 | 32.96 | -32 | 99.66 | 92.17 | 8 |
Powered by Capital Market - Live News